Citation Impact
Citing Papers
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
2010 Standout
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
2010
Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer
2007
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Determination of free and total (free plus protein-bound) melatonin in plasma and cerebrospinal fluid by high-performance liquid chromatography with fluorescence detection
2002
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
New Insights into the Biology of Renal Cell Carcinoma
2011 StandoutNobel
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Lipopolysaccharide-Squamous Cell Carcinoma-Monocyte Interactions Induce Cancer-Supporting Factors Leading to Rapid STAT3 Activation
2008
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Biotransformation of melatonin in human breast cancer cell lines: role of sulfotransferase 1A1
2005
Coordinated regulation of myeloid cells by tumours
2012 Standout
Melatonin and Breast Cancer: A Prospective Study
2004
Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants
2001
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Distribution, function and physiological role of melatonin in the lower gut
2011
Melatonin content in plasma and large intestine of patients with colorectal carcinoma before and after surgery
1999
The effect of melatonin on lipid peroxidation during radiotherapy in female rats
1999
Cancer-associated cachexia
2018 Standout
The melatonin-producing system is fully functional in retinal pigment epithelium (ARPE-19)
2009
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion
2001
Stress sensitivity in metastatic breast cancer: Analysis of hypothalamic–pituitary–adrenal axis function
2006
Purslane: a plant source of omega‐3 fatty acids and melatonin
2005 Standout
The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state
2015 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
2008
Male breast cancer
2006 Standout
Regulation of antioxidant enzymes: a significant role for melatonin
2003 Standout
Interleukin-6: An angiogenic target in solid tumours
2013
TGF-β and fibrosis in different organs — molecular pathway imprints
2009 Standout
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
EFFECT OF MELATONIN ON SLEEP QUALITY OF COPD INTENSIVE CARE PATIENTS: A PILOT STUDY
2000
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Melatonin as a natural ally against oxidative stress: a physicochemical examination
2011 Standout
The Role of Actigraphy in the Study of Sleep and Circadian Rhythms
2003 Standout
Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
2021
Novel treatment strategies in clear-cell metastatic renal cell carcinoma
2005
Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity
2024 StandoutNobel
Melatonin: structural characterization of its non‐enzymatic mono‐oxygenate metabolite
2003
Melatonin and its kynurenin-like oxidation products affect the microbicidal activity of neutrophils
2005
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
One molecule, many derivatives: A never‐ending interaction of melatonin with reactive oxygen and nitrogen species?
2006 Standout
Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages
2005
REVIEW: Gastrointestinal Melatonin: Localization, Function, and Clinical Relevance
2002 Standout
Advances in Malignant Mesothelioma
2005 Standout
Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox?
2016 Standout
Use of antioxidant supplements during breast cancer treatment: a comprehensive review
2008
Allogeneic Vaccination With a B7.1 HLA-A Gene-Modified Adenocarcinoma Cell Line in Patients With Advanced Non–Small-Cell Lung Cancer
2004
Melatonin as an Anti-Inflammatory Agent Modulating Inflammasome Activation
2017
Dendritic Cell-Based Vaccines: Clinical Applications in Breast Cancer
2014
Increased serum transforming growth factor-β1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration
2003
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Impact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell Carcinoma
2006
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
Dendritic cell dysfunction in cancer: A mechanism for immunosuppression
2005
Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer
2001
Economic analysis of targeting chemotherapy (CT) using a 21 gene RT-PCR assay in lymph node negative (LN-), estrogen receptor positive (ER+) early-stage breast cancer (ESBC)
2004
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer
2010
The light-dark regimen and cancer development.
2002
Carcinogenicity of shift-work, painting, and fire-fighting
2007 Standout
Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer
2002
Mechanisms of cancer inhibition by melatonin
2004
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
Antioxidants in cancer therapy; their actions and interactions with oncologic therapies.
1999
Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats
2003
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non–Small-Cell Lung Cancer
2006
Melatonin involvement in immunity and cancer
1998
Endogenous Melatonin Increases in Cerebrospinal Fluid of Patients after Severe Traumatic Brain Injury and Correlates with Oxidative Stress and Metabolic Disarray
2008
Works of Sofia Meregalli being referenced
Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients
2000
A Randomized Study of Low-Dose Subcutaneous lnterleukin-2 Plus Melatonin versus Supportive Care Alone in Metastatic Colorectal Cancer Patients Progressing under 5-Fluorouracil and Folates
1995
Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone
1995
Increased Survival Time in Brain Glioblastomas by a Radioneuroendocrine Strategy with Radiotherapy plus Melatonin Compared to Radiotherapy Alone
1996
Pretreatment serum markers and lymphocyte response to interleukin-2 therapy
1999
Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients.
2009
Are International Guidelines for the Prescription of Adjuvant Treatment for Early Breast Cancer Followed in Clinical Practice? Results of a Population-Based Study on 1547 Patients
2002
Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease.
2000
Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma
1996
A Randomized Study of Immunotherapy with Low-Dose Subcutaneous Interleukin-2 plus Melatonin Vs Chemotherapy with Cisplatin and Etoposide as First-Line Therapy for Advanced Non-Small Cell Lung Cancer
1994
Melatonin as a new possible anti-inflammatory agent.
1998
Dehydroepiandrosterone Sulfate (DHEAS) Secretion in Early and Advanced Solid Neoplasms: Selective Deficiency in Metastatic Disease
1998